Literature DB >> 3787168

The non-immune inflammatory response: serial changes in plasma iron, iron-binding capacity, lactoferrin, ferritin and C-reactive protein.

R Baynes, W Bezwoda, T Bothwell, Q Khan, N Mansoor.   

Abstract

The interrelationships between various components of the non-immune inflammatory response (white cell count, plasma lactoferrin, C-reactive protein, ferritin, iron and iron-binding capacity), were studied serially in a variety of inflammatory conditions including acute lobar pneumonia, active pulmonary tuberculosis, rheumatoid arthritis on gold therapy and sepsis in the face of marrow hypoplasia induced by chemotherapy. Lactoferrin concentrations paralleled the white count in all groups. They were highest in pneumonia and tuberculosis, mildly elevated in rheumatoid arthritis and markedly decreased in neutropenic sepsis. Very high initial lactoferrin concentrations were associated with a poor prognosis in acute pneumonia. C-reactive protein and ferritin concentrations remained elevated through the period of study in acute pneumonia and neutropenic sepsis, while they gradually normalised over weeks in subjects with tuberculosis or rheumatoid arthritis on therapy. In pneumonia and tuberculosis moderate hypoferraemia and a reduced iron-binding capacity were evident. In contrast, a raised percentage saturation was present in neutropenic sepsis, probably related to erythroid marrow suppression. Comparisons between ferritin, lactoferrin and C-reactive protein in the various groups supported the concept that ferritin behaves in part as an acute phase reactant and that hypoferraemia in inflammation is due to deviation of iron into ferritin stores. The suggestion that lactoferrin is responsible for the hypoferraemia and hyperferritinaemia was not supported by the present data. Iron deficiency appeared to limit the hyperferritinaemic response in rheumatoid arthritis, while erythropoietic inhibition by chemotherapy dampened the hypoferraemic response in neutropenic sepsis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3787168     DOI: 10.3109/00365518609083733

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  27 in total

1.  Obese women less likely to have low serum ferritin, Nicaragua.

Authors:  Amanda S Wendt; Maria E Jefferds; Cria G Perrine; Patricia Halleslevens; Kevin M Sullivan
Journal:  Public Health Nutr       Date:  2014-05-22       Impact factor: 4.022

2.  Iron-independent induction of ferritin H chain by tumor necrosis factor.

Authors:  L L Miller; S C Miller; S V Torti; Y Tsuji; F M Torti
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

3.  Response of body temperature and serum iron concentration to repeated pyrogen injection in rabbits.

Authors:  K Goelst; H Laburn
Journal:  Pflugers Arch       Date:  1991-02       Impact factor: 3.657

4.  Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage.

Authors:  Magdy Selim; Sharon Yeatts; Joshua N Goldstein; Joao Gomes; Steven Greenberg; Lewis B Morgenstern; Gottfried Schlaug; Michel Torbey; Bonnie Waldman; Guohua Xi; Yuko Palesch
Journal:  Stroke       Date:  2011-08-25       Impact factor: 7.914

Review 5.  Clinical pharmacokinetics of iron preparations.

Authors:  E Harju
Journal:  Clin Pharmacokinet       Date:  1989-08       Impact factor: 6.447

6.  The acute phase response and exercise: court and field sports.

Authors:  K E Fallon; S K Fallon; T Boston
Journal:  Br J Sports Med       Date:  2001-06       Impact factor: 13.800

Review 7.  Biomarkers of Nutrition for Development (BOND)-Iron Review.

Authors:  Sean Lynch; Christine M Pfeiffer; Michael K Georgieff; Gary Brittenham; Susan Fairweather-Tait; Richard F Hurrell; Harry J McArdle; Daniel J Raiten
Journal:  J Nutr       Date:  2018-06-01       Impact factor: 4.798

8.  Interleukin 1 administration in mice produces hypoferremia despite neutropenia.

Authors:  V R Gordeuk; P Prithviraj; T Dolinar; G M Brittenham
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

Review 9.  Hydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemias.

Authors:  Wai Cheng Foong; Jacqueline J Ho; C Khai Loh; Vip Viprakasit
Journal:  Cochrane Database Syst Rev       Date:  2016-10-18

10.  Hyperferritinemia in pulmonary tuberculosis.

Authors:  Benedicta D'Souza; Sulekha Sinha; Poornima Manjrekar; Vivian D'Souza
Journal:  Indian J Clin Biochem       Date:  2012-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.